Harpoon Therapeutics, Inc.
EPCAM BINDING PROTEINS AND METHODS OF USE
Last updated:
Abstract:
Provided herein are EpCAM binding proteins, pharmaceutical compositions comprising such proteins or fragments thereof, as well as nucleic acids, recombinant expression vectors and host cells for making such EpCAM binding proteins. Also disclosed are methods of using the disclosed EpCAM binding proteins in the prevention, and/or treatment diseases, conditions and disorders.
Status:
Application
Type:
Utility
Filling date:
14 May 2020
Issue date:
25 Aug 2022